These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3080002)
1. Inhibition of purine nucleoside phosphorylase by 9-(phosphonoalkyl)hypoxanthines. Nakamura CE; Chu SH; Stoeckler JD; Parks RE Biochem Pharmacol; 1986 Jan; 35(2):133-6. PubMed ID: 3080002 [No Abstract] [Full Text] [Related]
2. Synthesis of 9-(3,4-dioxopentyl)hypoxanthine, the first arginine-directed purine derivative: an irreversible inactivator for purine nucleoside phosphorylase. Salamone SJ; Jordan F Biochemistry; 1982 Dec; 21(25):6383-8. PubMed ID: 6817790 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions. Stoeckler JD; Cambor C; Kuhns V; Chu SH; Parks RE Biochem Pharmacol; 1982 Jan; 31(2):163-71. PubMed ID: 6800381 [No Abstract] [Full Text] [Related]
4. [Inactivation by 4,6 disubstituted pyrazolo (3,4-d) pyrimidines of the arsenolysis of guanosine by erythrocyte purine nucleoside phosphorylase]. Thang KV; Delbarre F; Auscher C; Gerbaut L C R Acad Hebd Seances Acad Sci D; 1977 Feb; 284(6):481-3. PubMed ID: 404078 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of purine nucleoside phosphorylase by modification of arginine residues. Jordan F; Wu A Arch Biochem Biophys; 1978 Oct; 190(2):699-704. PubMed ID: 102259 [No Abstract] [Full Text] [Related]